Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.494
Bid: 1.472
Ask: 1.506
Change: -0.006 (-0.40%)
Spread: 0.034 (2.31%)
Open: 1.53
High: 1.53
Low: 1.462
Prev. Close: 1.50
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB FY20 Year End Separate Financial Results

1 Mar 2021 07:00

RNS Number : 6096Q
Commercial Intnl Bank (Egypt) SAE
01 March 2021
 

Click on, or paste the following link into your web browser, to view the associated PDF document

http://www.rns-pdf.londonstockexchange.com/rns/6096Q_1-2021-3-1.pdf

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate balance sheet as at December 31, 2020

 

 

Notes

Dec. 31, 2020

 

Dec. 31, 2019

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

Assets

 

 

 

 

 

Cash and balances at the central bank

15

33,572,597

 

28,273,962

 

Due from banks

16

86,997,034

 

28,353,366

 

Loans and advances to banks, net

18

776,980

 

625,264

 

Loans and advances to customers, net

19

118,854,880

 

119,321,103

 

Derivative financial instruments

20

248,759

 

216,383

 

Investments

 

 

 

 

 

- Financial Assets at Fair Value through P&L

21

359,959

 

418,781

 

- Financial Assets at Fair Value through OCI

21

147,646,432

 

89,897,257

 

- Amortized cost

21

25,020,917

 

107,225,613

 

- Investments in associates and subsidiaries

22

874,348

 

63,953

 

Other assets

23

9,095,212

 

9,747,939

 

Deferred tax assets (Liabilities)

31

437,772

 

350,339

 

Property and equipment

24

2,259,940

 

2,202,698

 

Total assets

 

426,144,830

 

386,696,658

 

Liabilities and equity

 

 

 

 

 

Liabilities

 

 

 

 

 

Due to banks

25

8,815,561

 

11,810,607

 

Due to customers

26

340,086,524

 

304,483,655

 

Derivative financial instruments

20

331,073

 

282,588

 

Current tax liabilities

 

859,582

 

4,639,364

 

Other liabilities

28

5,679,266

 

8,396,487

 

Other loans

27

7,746,946

 

3,272,746

 

Provisions

29

3,221,252

 

2,011,369

 

Total liabilities

 

366,740,204

 

334,896,816

 

Equity

 

 

 

 

 

Issued and paid up capital

30

14,776,813

 

14,690,821

 

Reserves

33

33,085,554

 

24,342,314

 

Reserve for employee stock ownership plan (ESOP)

33

1,064,648

 

963,152

 

Retained earnings *

33

10,477,611

 

11,803,555

 

Total equity

 

59,404,626

 

51,799,842

 

Total liabilities and equity

 

426,144,830

 

386,696,658

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

(Audit report attached)

 

 

 

 

*

Including net profit for the current year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Board member

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate income statement for the year ended December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes

 

 

Dec. 31, 2020

Dec. 31, 2019

 

 

 

 

 

 

 

 

 

EGP Thousands

EGP Thousands

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest and similar income

 

 

 

42,070,598

42,600,957

 

 

 

 

 

Interest and similar expense

 

 

 

(16,980,635)

(21,022,838)

 

 

 

 

 

Net interest income

6

 

 

25,089,963

21,578,119

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fee and commission income

 

 

 

3,053,536

3,451,688

 

 

 

 

 

Fee and commission expense

 

 

 

(983,450)

(1,170,893)

 

 

 

 

 

Net fee and commission income

7

 

 

2,070,086

2,280,795

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividend income

8

 

 

98,175

53,423

 

 

 

 

 

Net trading income

9

 

 

395,701

688,059

 

 

 

 

 

Profits (Losses) on financial investments

21

 

 

922,832

450,697

 

 

 

 

 

Administrative expenses

10

 

 

(5,552,800)

(5,044,937)

 

 

 

 

 

Other operating (expenses) income

11

 

 

(2,737,550)

(1,794,540)

 

 

 

 

 

Intangible assets amortization

 

 

 

-

(238,715)

 

 

 

 

 

Impairment release (charges) for credit losses

12

 

 

(4,989,288)

(1,435,460)

 

 

 

 

 

Profit before income tax

 

 

 

15,297,119

16,537,441

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

13

 

 

(5,084,670)

(4,639,364)

 

 

 

 

 

Deferred tax assets (Liabilities)

31 - 13

 

 

87,433

(94,522)

 

 

 

 

 

Net profit for the year

 

 

 

10,299,882

11,803,555

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earning per share

14

 

 

 

 

 

 

 

 

 

Basic

 

 

 

6.26

7.12

 

 

 

 

 

Diluted

 

 

 

6.24

7.09

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

 

Sherif Samy

 

 

 

 

 

 

CEO & Board member

 

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate statement of other comprehensive income for the year ended December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

Dec. 31, 2020

 

Dec. 31, 2019

 

 

 

 

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

 

 

 

 

Net profit for the year

 

 

 

10,299,882

 

11,803,555

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income items that will not be reclassified to the Profit or Loss:

 

 

 

 

 

 

 

 

Change in fair value of equity instruments measured at fair value through other comprehensive income

 

 

 

(13,966)

 

212,967

 

 

Other comprehensive income items that is or may be reclassified to the profit or loss:

 

 

 

 

 

 

 

 

Change in fair value of debt instruments measured at fair value through other comprehensive income

 

 

 

(255,293)

 

5,944,586

 

 

Transferred from reserve on disposal of financial assets at fair value through OCI

 

 

 

(76,717)

 

-

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

 

 

 

205,182

 

(184,921)

 

 

Total other comprehensive income for the year

 

 

 

10,159,088

 

17,776,187

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate cash flow for the year ended December 31, 2020

 

 

 

 

 

 

 

 

Notes

Dec. 31, 2020

 

Dec. 31, 2019

 

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

 

Profit before income tax

 

15,297,119

 

16,537,441

 

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

 

 

 

Fixed assets depreciation

24

677,501

 

576,544

 

Impairment charge for credit losses (Loans and advances to customers and banks)

12

4,777,592

 

1,610,878

 

Other provisions charges

29

1,232,731

 

461,869

 

Impairment charge for credit losses (due from banks)

12

6,514

 

9,503

 

Impairment charge for credit losses (financial investments)

12

205,182

 

(184,921)

 

Impairment charge for other assets

23

69,217

 

(93,313)

 

Exchange revaluation differences for financial assets at fair value through OCI

21

249,642

 

1,593,030

 

Intangible assets amortization

 

-

 

238,715

 

Impairment charge financial assets at fair value through OCI

21

79,126

 

47,197

 

Utilization of other provisions

29

(2,382)

 

(28,135)

 

Other provisions no longer used

29

(13,273)

 

(6,910)

 

Exchange differences of other provisions

29

(7,193)

 

(110,062)

 

(Profits) losses from selling property, plant and equipment

11

(1,094)

 

(1,439)

 

(Profits) losses from selling financial investments

21

(1,018,469)

 

(497,894)

 

Shares based payments

 

552,438

 

464,539

 

Released (Impairment) charges of investments in associates and subsidiaries

21

16,511

 

-

 

Operating profits before changes in operating assets and liabilities

 

22,121,162

 

20,617,042

 

 

 

 

 

 

 

Net decrease (increase) in assets and liabilities

 

 

 

 

 

Due from banks

15

(10,899,927)

 

(8,870,547)

 

Financial assets at fair value through P&L

21

58,822

 

2,318,924

 

Derivative financial instruments

20

16,109

 

(2,910)

 

Loans and advances to banks and customers

18 - 19

(4,276,558)

 

(14,533,328)

 

Other assets

40

649,301

 

162,502

 

Due to banks

25

(2,995,046)

 

4,550,788

 

Due to customers

26

35,602,869

 

19,143,183

 

Income tax obligations paid

 

(3,779,782)

 

(3,625,579)

 

Other liabilities

28

(7,700,878)

 

1,894,934

 

Net cash used in (generated from) operating activities

 

28,796,072

 

21,655,009

 

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

 

Proceeds from investments in associates.

 

750

 

-

 

Payments for investment in subsidiaries and associates.

 

(721,352)

 

-

 

Payment for purchases of property, plant, equipment and branches constructions

 

(987,061)

 

(1,301,415)

 

Proceeds from selling property, plant and equipment

11

1,094

 

1,439

 

Proceeds from redemption of financial assets at amortized cost

21

82,203,469

 

43,937,957

 

Payment for purchases of financial assets at amortized cost

21

-

 

(76,516,842)

 

Payment for purchases of financial assets at fair value through OCI

21

(112,382,696)

 

(50,954,311)

 

Proceeds from selling financial assets at fair value through OCI

 

54,970,226

 

54,813,449

 

Net cash generated from (used in) investing activities

 

23,084,430

 

(30,019,723)

 

 

Separate cash flow for the year ended December 31, 2020 (Cont.)

 

 

 

 

 

 

 

 

 

 

Dec. 31, 2020

 

Dec. 31, 2019

 

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

 

Received (Repaid) in long term loans

27

4,474,200

 

(448,783)

 

Dividend paid

 

(3,370,464)

 

(2,700,544)

 

Capital increase

 

85,992

 

105,413

 

Net cash generated from (used in) financing activities

 

1,189,728

 

(3,043,914)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalent during the year

 

53,070,230

 

(11,408,628)

 

Beginning balance of cash and cash equivalent

 

22,895,017

 

34,303,645

 

Cash and cash equivalent at the end of the year

 

75,965,247

 

22,895,017

 

 

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

 

Cash and balances at the central bank

15

33,572,597

 

28,273,962

 

Due from banks

16

87,020,365

 

28,370,183

 

Treasury bills and other governmental notes

17

39,464,714

 

27,634,062

 

Obligatory reserve balance with CBE

15

(27,610,380)

 

(22,397,310)

 

Due from banks with maturities more than three months

 

(16,280,760)

 

(10,593,903)

 

Treasury bills with maturity more than three months

 

(40,201,289)

 

(28,391,977)

 

Total cash and cash equivalent

 

75,965,247

 

22,895,017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate statement of changes in shareholders' equity for the year ended December 31, 2019

Dec. 31, 2019

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

11,668,326

1,710,293

12,776,215

1,549,445

12,421

(1,860,851)

4,323

9,555,755

738,320

36,154,247

Capital increase

3,022,495

-

(2,917,082)

-

-

-

-

-

-

105,413

Transferred to reserves

-

477,736

6,615,296

-

1,045

-

-

(6,854,370)

(239,707)

-

Dividend paid

-

-

-

-

-

-

-

(2,700,544)

-

(2,700,544)

Net profit for the year

-

-

-

-

-

-

-

11,803,555

-

11,803,555

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

6,157,553

-

-

-

6,157,553

Transferred (from) to bank risk reserve

-

-

-

-

-

-

841

(841)

-

-

ECL for impairment of debt instruments investments

-

-

-

-

-

(184,921)

-

-

-

(184,921)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

464,539

464,539

Ending balance

14,690,821

2,188,029

16,474,429

1,549,445

13,466

4,111,781

5,164

11,803,555

963,152

51,799,842

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate statement of changes in shareholders' equity for the year ended December 31, 2020

Dec. 31, 2020

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

14,690,821

2,188,029

16,474,429

1,549,445

13,466

4,111,781

5,164

11,803,555

963,152

51,799,842

Capital increase

85,992

-

-

-

-

-

-

-

-

85,992

Transferred to reserves

-

590,106

8,291,229

-

1,440

-

-

(8,431,833)

(450,942)

-

Dividend paid

-

-

-

-

-

-

-

(3,370,464)

-

(3,370,464)

Net profit for the year

-

-

-

-

-

-

-

10,299,882

-

10,299,882

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

(76,717)

-

76,717

-

-

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

101,013

-

101,013

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(269,259)

-

-

-

(269,259)

Transferred (from) to banking risk reserve

-

-

-

-

-

-

1,259

(1,259)

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

 

-

205,182

-

-

-

205,182

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

552,438

552,438

Ending balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proposed appropriation account for the year ended December 31, 2020

 

 

 

 

 

 

 

 

Dec. 31, 2020

 

Dec. 31, 2019

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

Net profit after tax

10,299,882

 

11,803,555

 

Profits selling property, plant and equipment transferred to capital reserve according to the law

(1,094)

 

(1,439)

 

Bank risk reserve

(2,718)

 

(1,258)

 

Available net profit for distributing

10,296,070

 

11,800,858

 

 

 

 

 

 

To be distributed as follows:

 

 

 

 

Legal reserve

514,939

 

590,106

 

General reserve

8,420,479

 

7,840,287

 

Dividends to shareholders

-

 

1,836,353

 

Staff profit sharing

1,029,607

 

1,180,086

 

Board members bonus

73,643

 

177,013

 

CIB's foundation

154,441

 

177,013

 

Support and development of banking sector fund

102,961

 

-

 

Total

10,296,070

 

11,800,858

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR FIFLIVLILIIL
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.